Knockdown of YTHDF1 inhibited NSCLC cell growth and the formation of xenograft tumor by adjusting the translational efficiency of CDK2, CDK4, and cyclin D1 and also restrained de novo lung adenocarcinoma progression. Here, YTHDF1 is linked to non-small cell lung carcinoma.